Serious Materials Inc.
Investors: Mesirow Financial Capital (led), New Enterprise Associates, Foundation Capital, Navitas Capital, Rustic Canyon Partners, Enertech Capital, Cheyenne, and Saints Capital.
Details: Develops green building materials. The company previously raised about $52M in funding.
Investors: Greener Capital.
Details: Operates an online sales company for residential solar service. Charles Finnie, managing partner in Greener Capital, has joined the board.
Chelsio Communications Inc.
Details: Develops 10-gigabit Ethernet technology. The funding is the first close on a $16M funding round, according to a regulatory filing. The company previously raised about $84M from Investor Growth Capital, New Enterprise Associates, Invesco Private Capital, LSI Logic Corp., Hotung Capital Management, Abacus Capital Group, Pacesetter Capital Group and Horizon Ventures.
Details: Develops an online retail platform for the manufacturers and customers in the consumer packaged goods market. The funding is the first close of a $6M second round of VC funding, according to a regulatory filing. The company previously raised $4.3M from Kegonsa Capital Partners and DaneVest Tech Fund.
FOOD & BEVERAGES
Details: Develops ice cream machines for consumers to make hard-scoop ice cream in 40 seconds. The funding will be used to support the company’s initial product rollout.
Alliance Health Networks Inc.
Salt Lake City
Investors: Highway 12 Ventures (led) and EPIC Ventures.
Details: Operates health care-related social networks. The company has now raised $6.6M in total funding.
Investors: Newbury Ventures.
Details: Develops an online search engine for tracking life sciences data. The company raised a $7M funding round in mid-2007.
Authentic Response Inc.
Investors: Sutter Hill Ventures.
Details: Provides online sampling and data collection. The company also announced that Jim Follett, former CEO of Survey Sampling International, will take over as CEO. He succeeds interim CEO Matt Blumberg of Return Path, from which Authentic Response spun out last year.
The Rubicon Project
Investors: Peacock Equity Fund (led), Clearstone Venture Partners and Mayfield Fund.
Details: Provides Internet advertising optimizing services and infrastructure. Returning investor Peacock Equity, which invests from a $250M fund launched by GE Capital and NBC Universal in 2007, led the Series C round with $6M. The company has now raised $42M in equity and debt funding.
Palo Alto, Calif.
Investors: Highland Capital Partners, Worldview Technology Partners and Cardinal Capital Partners.
Details: Provides a direct mobile response marketing service. The company previously raised about $23M in funding.
Calypso Medical Technologies Inc.
Investors: Skyline Ventures (co-led), Frazier Healthcare Ventures (co-led), Bay City Capital and InterWest Partners.
Details: Develops real-time localization technology used for tracking tumor targets. The company has now raised nearly $175M in total VC funding since 1999.
Gamma Medica-Ideas Inc.
Investors: Psilos Group (led) and Capital Resource Partners.
Details: Develops digital molecular imaging systems. Psilos led the round with $14M in equity.
Investors: St, Jude medical Inc.
Details: Develops interventional cardiology systems. The company had previously raised VC funding from Invemed Catalyst Fund and the GE Pension Plan.
Investors: CHL Medical Partners (led), Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Co. and the Invus Group.
Details: Develops molecular diagnostics technology. Ronald Lennox of CHL Medical Partners has joined the board. Earlier this month, Primera raised $1.5M in debt financing, according to a regulatory filing. The company previously raised a $21M Series B round of funding from Abingworth and was spun out from Providence, R.I.-based life sciences company Sention Inc.
Sleep Solutions Inc.
Investors: Quaker BioVentures and MedVenture Associates.
Details: Develops medical technologies to treat sleep disorder. Adele Oliva of Quaker BioVentures has joined the board. The company previously raised more than $46M in VC funding from TPG Biotech, MedVenture Associates, Emergent Ventures and Lava Ventures.
Juvaris BioTherapeutics Inc.
Investors: SV Life Sciences (led) and Kleiner Perkins Caufield & Byers.
Details: Develops vaccines for cancer and infectious diseases. The funding is the first close of a Series B round.
Details: Develops focused on treating autism and Fragile X syndrome.
Investors: StarVest Partners (led), Jefferson Partners and The Entrepreneurs Fund.
Details: Develops on-demand software for research and development.
Investors: Individual investor and CEO Clay Mathile and undisclosed investors.
Details: Develops interactive video software and services. The company previously raised more than $58M in VC funding from Westbury Partners and Fortuna Investments.
Investors: Undisclosed individual investors.
Details: Develops software that enables the deployment of 4G wireless networks.
Investors: Jafco Ventures (led) and New Enterprise Associates.
Details: Develops mobile video search and delivery solutions. Nick Sturiale, general partner at Jafco, will join the board, which also includes Kittu Kolluri, general partner at NEA.